{"We": [0, 175], "describe": [1], "a": [2, 19, 35, 129, 150, 210, 359], "recently": [3], "recognized": [4], "disease": [5, 360], "entity,": [6], "limbic-predominant": [7], "age-related": [8], "TDP-43": [9, 21, 37, 61, 78, 201], "encephalopathy": [10], "(LATE).": [11], "LATE": [12, 53, 137, 287], "neuropathological": [13], "change": [14], "(LATE-NC)": [15], "is": [16, 34, 54, 198, 321, 341], "defined": [17], "by": [18], "stereotypical": [20], "proteinopathy": [22], "in": [23, 49, 134, 248, 308, 315, 331, 389], "older": [24, 70], "adults,": [25], "with": [26, 40, 60, 95, 101, 200, 243, 267, 291], "or": [27, 349], "without": [28], "coexisting": [29], "hippocampal": [30], "sclerosis": [31], "pathology.": [32], "LATE-NC": [33, 91, 102, 222, 244], "common": [36], "proteinopathy,": [38], "associated": [39, 94], "an": [41, 139, 193, 322], "amnestic": [42], "dementia": [43, 48], "syndrome": [44], "that": [45, 114, 241, 286], "mimicked": [46], "Alzheimer's-type": [47], "retrospective": [50], "autopsy": [51, 82, 189], "studies.": [52], "distinguished": [55], "from": [56, 205], "frontotemporal": [57, 293], "lobar": [58, 294], "degeneration": [59, 295], "pathology": [62], "based": [63], "on": [64, 144, 203, 328], "its": [65], "epidemiology": [66], "(LATE": [67], "generally": [68], "affects": [69], "subjects),": [71], "and": [72, 111, 123, 166, 183, 218, 255, 276, 296, 318, 333, 375], "relatively": [73], "restricted": [74], "neuroanatomical": [75], "distribution": [76], "of": [77, 85, 90, 125, 170, 185, 191, 213, 280, 311, 343, 355, 358, 378], "proteinopathy.": [79], "In": [80], "community-based": [81], "cohorts,": [83], "\u223c25%": [84], "brains": [86], "had": [87, 246], "sufficient": [88], "burden": [89], "to": [92, 155, 163, 167, 173, 224, 338, 367], "be": [93], "discernible": [96], "cognitive": [97], "impairment.": [98], "Many": [99], "subjects": [100, 124, 242], "have": [103, 261], "comorbid": [104], "brain": [105, 207, 214, 257], "pathologies,": [106], "often": [107], "including": [108, 179, 330], "amyloid-\u03b2": [109], "plaques": [110], "tauopathy.": [112], "Given": [113], "the": [115, 226, 249, 370], "'oldest-old'": [116], "are": [117, 236], "at": [118], "greatest": [119], "risk": [120, 268, 283, 371], "for": [121, 159, 181, 270, 325, 352, 386], "LATE-NC,": [122, 192], "advanced": [126], "age": [127], "constitute": [128], "rapidly": [130], "growing": [131], "demographic": [132], "group": [133, 152], "many": [135], "countries,": [136], "has": [138], "expanding": [140], "but": [141, 232, 299], "under-recognized": [142], "impact": [143], "public": [145], "health.": [146], "For": [147, 187, 313], "these": [148, 281], "reasons,": [149], "working": [151], "was": [153], "convened": [154], "develop": [156], "diagnostic": [157, 344], "criteria": [158], "LATE,": [160, 329, 379], "aiming": [161], "both": [162, 292], "stimulate": [164], "research": [165, 326], "promote": [168], "awareness": [169], "this": [171], "pathway": [172], "dementia.": [174], "report": [176], "consensus-based": [177], "recommendations": [178], "guidelines": [180], "diagnosis": [182], "staging": [184, 196], "LATE-NC.": [186], "routine": [188], "workup": [190], "anatomically-based": [194], "preliminary": [195], "scheme": [197], "proposed": [199], "immunohistochemistry": [202], "tissue": [204], "three": [206], "areas,": [208], "reflecting": [209], "hierarchical": [211], "pattern": [212], "involvement:": [215], "amygdala,": [216], "hippocampus,": [217], "middle": [219], "frontal": [220, 253], "gyrus.": [221], "appears": [223], "affect": [225], "medial": [227, 250], "temporal": [228, 251], "lobe": [229], "structures": [230], "preferentially,": [231], "other": [233, 256], "areas": [234], "also": [235, 245, 300], "impacted.": [237], "Neuroimaging": [238], "studies": [239, 260, 365], "demonstrated": [240], "atrophy": [247], "lobes,": [252], "cortex,": [254], "regions.": [258], "Genetic": [259], "thus": [262], "far": [263], "indicated": [264], "five": [265], "genes": [266], "alleles": [269], "LATE-NC:": [271], "GRN,": [272], "TMEM106B,": [273], "ABCC9,": [274], "KCNMB2,": [275], "APOE.": [277], "The": [278], "discovery": [279], "genetic": [282], "variants": [284], "indicate": [285], "shares": [288], "pathogenetic": [289], "mechanisms": [290], "Alzheimer's": [297], "disease,": [298], "suggests": [301], "disease-specific": [302], "underlying": [303], "mechanisms.": [304], "Large": [305], "gaps": [306], "remain": [307], "our": [309], "understanding": [310], "LATE.": [312, 356], "advances": [314], "prevention,": [316], "diagnosis,": [317], "treatment,": [319], "there": [320], "urgent": [323], "need": [324], "focused": [327], "vitro": [332], "animal": [334], "models.": [335], "An": [336], "obstacle": [337], "clinical": [339, 376, 390], "progress": [340], "lack": [342], "tools,": [345], "such": [346], "as": [347, 380, 382], "biofluid": [348], "neuroimaging": [350], "biomarkers,": [351], "ante-mortem": [353], "detection": [354], "Development": [357], "biomarker": [361], "would": [362], "augment": [363], "observational": [364], "seeking": [366], "further": [368], "define": [369], "factors,": [372], "natural": [373], "history,": [374], "features": [377], "well": [381], "eventual": [383], "subject": [384], "recruitment": [385], "targeted": [387], "therapies": [388], "trials.": [391]}